High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$205K
$205,797
Total Sells (Filtered)
$258K
$258,671
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RNAC |
Cartesian Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2026-01-06 | $72,227 | S | Form 4 |
|
RNAC
S
Cartesian Therapeutics, Inc.
Miljkovic Milos
• Officer • Chief Medical Officer
Discretionary Sell
2026-01-06
$24,367
|
||||||
| RNAC |
Cartesian Therapeutics, Inc.
|
Officer • Chief Medical Officer
Discretionary Sell
|
2026-01-06 | $24,367 | S | Form 4 |
| RNAC |
Cartesian Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2026-01-06 | $162,077 | S | Form 4 |
|
RNAC
P
Cartesian Therapeutics, Inc.
BARABE TIMOTHY C
• Director
Discretionary BuyΔOwn +123.1%
2025-12-04
$205,797
|
||||||
| RNAC |
Cartesian Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +123.1%
|
2025-12-04 | $205,797 | P | Form 4 |
|
RNAC
M
Cartesian Therapeutics, Inc.
English Emily
• Officer • Chief Operations Officer
Other
2025-11-28
$24,750
|
||||||
| RNAC |
Cartesian Therapeutics, Inc.
|
Officer • Chief Operations Officer
Other
|
2025-11-28 | $24,750 | M | Form 4 |
|
RNAC
M
Cartesian Therapeutics, Inc.
English Emily
• Officer • Chief Operations Officer
Equity Compensation
2025-11-28
$0
|
||||||
| RNAC |
Cartesian Therapeutics, Inc.
|
Officer • Chief Operations Officer
Equity Compensation
|
2025-11-28 | $0 | M | Form 4 |